Cite
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
MLA
Michio Hirano, et al. Deoxypyrimidine Monophosphate Bypass Therapy for Thymidine Kinase 2 Deficiency. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2ab04c8737e6aeb867e8c1de8e746e9&authtype=sso&custid=ns315887.
APA
Michio Hirano, Hasan O. Akman, Kurenai Tanji, Luis C. López, Catarina M. Quinzii, Saba Tadesse, Beatriz Garcia-Diaz, Caterina Garone, & Valentina Emmanuele. (2014). Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.
Chicago
Michio Hirano, Hasan O. Akman, Kurenai Tanji, Luis C. López, Catarina M. Quinzii, Saba Tadesse, Beatriz Garcia-Diaz, Caterina Garone, and Valentina Emmanuele. 2014. “Deoxypyrimidine Monophosphate Bypass Therapy for Thymidine Kinase 2 Deficiency,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2ab04c8737e6aeb867e8c1de8e746e9&authtype=sso&custid=ns315887.